CapsoVision, Inc. Common Stock

NASDAQ:CV USA Medical Devices
Market Cap
$258.57 Million
Market Cap Rank
#16220 Global
#6270 in USA
Share Price
$5.52
Change (1 day)
+7.39%
52-Week Range
$3.56 - $14.42
All Time High
$14.42
About

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. It offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps… Read more

CapsoVision, Inc. Common Stock (CV) - Total Liabilities

Latest total liabilities as of September 2025: $5.22 Million USD

Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) has total liabilities worth $5.22 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

CapsoVision, Inc. Common Stock - Total Liabilities Trend (2023–2024)

This chart illustrates how CapsoVision, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

CapsoVision, Inc. Common Stock Competitors by Total Liabilities

The table below lists competitors of CapsoVision, Inc. Common Stock ranked by their total liabilities.

Company Country Total Liabilities
Trusval Technology Co Ltd
TWO:6667
Taiwan NT$3.60 Billion
Zhejiang Yiming Food Co. Ltd.
SHG:605179
China CN¥1.79 Billion
Kcc Glass Corp
KO:344820
Korea ₩939.09 Billion
Safilo Group S.p.A
PINK:SAFLF
USA $386.86 Million
Serko Limited
PINK:SERKF
USA $30.97 Million
Hangzhou Landscaping Incorporated
SHG:605303
China CN¥1.06 Billion
TortoiseEcofin Acquisition Corp. III
PINK:TRTLF
USA $15.52 Million

Liability Composition Analysis (2023–2024)

This chart breaks down CapsoVision, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.19 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.26 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.20 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CapsoVision, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CapsoVision, Inc. Common Stock (2023–2024)

The table below shows the annual total liabilities of CapsoVision, Inc. Common Stock from 2023 to 2024.

Year Total Liabilities Change
2024-12-31 $146.31 Million +11.37%
2023-12-31 $131.37 Million --